We recently published a list of 10 Stocks That Will Profit From AI. In this article, we are going to take a look at where ...
The February 2025 acquisition of Ambry Genetics further expands TEM's genomics capabilities with a West Coast lab and ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the company is scheduled to exhibit 4 abstracts at the ...
Tempus AI leverages AI for treatment decisions and diagnostics, thriving in the booming healthcare AI market with strong ...
We recently published a list of 10 Stocks Lead Friday’s Charge. In this article, we are going to take a look at where Tempus AI (NASDAQ:TEM) stands against other stocks that lead Friday’s charge.
Tempus AI stock surged 40% YTD, driven by acquisitions and investor confidence in healthcare AI. Can its momentum spark ...
On Tuesday, Cathie Wood-led Ark Invest made significant trades involving Tempus AI Inc. TEM, Advanced Micro Devices Inc. AMD, and Meta Platforms Inc. META. The Tempus AI Trade saw Ark ...
Tempus AI started off the year with a stellar ... a 79% YoY growth, bolstered by the Ambry Genetics acquisition and a rapidly growing TAM. Despite the deep selloff recently, I rank TEM a 'Strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results